Mon panier

Mouse IL-13 R alpha 1 Protein, Fc Tag

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
IL1-M5258-200ug
$325.00
IL1-M5258-1mg (500ug X 2)
$1495.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    IL13RA1, CD213A1, IL-13Ra, NR4, RP13-128O4.2, IL13Rα1

  • Source

    Mouse IL-13RA1, Fc Tag (IL1-M5258) is expressed from human 293 cells (HEK293). It contains AA Ala 26 - Thr 340 (Accession # NP_598751).

    Predicted N-terminus: Ala 26

    Request for sequence
  • Molecular Characterization

    IL-13 R alpha 1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 62.7 kDa. The protein migrates as 67-100 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    IL-13 R alpha 1 SDS-PAGE

    Mouse IL-13RA1, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • Bioactivity-ELISA

     IL-13 R alpha 1 ELISA

    Immobilized Mouse IL-13RA1, Fc Tag (Cat. No. IL1-M5258) at 2 μg/mL (100 μL/well) can bind Human IL-13 Protein, His Tag, premium grade (Cat. No. IL3-H52H3) with a linear range of 0.005-0.156 μg/mL (QC tested).

    Protocol
  •  IL-13 R alpha 1 ELISA

    Immobilized Mouse IL-13, His Tag (Cat. No. IL3-M5249) at 5 μg/mL (100 μL/well) can bind Mouse IL-13RA1, Fc Tag (Cat. No. IL1-M5258) with a linear range of 0.3-5 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-BLI

     IL-13 R alpha 1 BLI

    Loaded Mouse IL-13RA1, Fc Tag (Cat. No. IL1-M5258) on Protein A Biosensor, can bind Human IL-13 Protein, His Tag, premium grade (Cat. No. IL3-H52H3) with an affinity constant of 17.2 nM as determined in BLI assay (ForteBio Octet R8) (Routinely tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Interleukin 13 receptor, alpha 1 is also known as IL13RA1, NR4 and CD213A1 (cluster of differentiation 213A1), The IL13 Rα1 cD encodes a 427 amino acid (aa) residue precursor protein with a putative 21 aa residue signal peptide, a 324 aa residue extracellular domain, a 23 aa residue transmembrane region and a 59 aa residue cytoplasmic tail. Human and mouseIL13Rα1 share 76% aa sequence identity. IL13RA1 is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Interleukin-13 receptor subunit alpha-1

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    1 Détails

  • Étape de développement la plus élevée:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte